David joined the Relief team in August 2022 as U.S. Market Lead. He brings more than 20 years of relevant commercial development and market access experience in the pharmaceutical industry. Prior to Relief, David was National Account Director (Payer Account Lead) at Mirum Pharmaceuticals, Inc., a biopharmaceutical company focused on the treatment of rare diseases, where he was responsible for building out the company’s Medicaid launch strategy and supporting the expansion of key market access policies. Previously, he held positions of increasing responsibility at Novartis Gene Therapies (formerly AveXis), most recently, as Director National Accounts, where he was responsible for successfully negotiating multiple Value-Based Agreements and 10 state Medicaid policies. Before that, he was a Patient Access Liaison at Spark Therapeutics, supporting the launch of a first-of-its-kind gene therapy in the inherited retinal disease space and aiding in the build-out of patient services and market access operations. David earned a BA in Speech/Public Relations from McNeese State University, a BS in Ministry and Theology from St. Louis Christian College and served four years in the United States Coast Guard.